Location History:
- Guntershausen b. Aadorf, CH (2007)
- Basel, CH (2017 - 2022)
Company Filing History:
Years Active: 2007-2025
Title: Innovator Spotlight: Markus Weiss from Basel, CH
Introduction: Markus Weiss, an accomplished inventor based in Basel, Switzerland, has made significant contributions to the field of medicine with his innovative research. With a total of four patents to his name, Weiss is renowned for developing methods that enhance therapeutic responses in patients facing cognitive impairments and neurodegenerative disorders.
Latest Patents: One of his latest patents involves a biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment. This invention presents methods for predicting the therapeutic responsiveness of subjects suffering from cognitive dysfunctions and psychotic disorders to this specific treatment. The significance of this innovation lies in its potential to improve treatment outcomes for individuals afflicted by challenging cognitive conditions.
Career Highlights: Currently, Markus Weiss is a dedicated member of Novartis AG, a global healthcare company known for its groundbreaking research and innovative pharmaceutical solutions. His work at Novartis reflects his commitment to advancing medical science through the development of effective therapeutic strategies.
Collaborations: Throughout his career, Weiss has collaborated with notable colleagues such as Donald Johns and Cristina Lopez-Lopez. These partnerships have facilitated a knowledge exchange and fostered a collaborative environment that enhances the innovation process.
Conclusion: Markus Weiss continues to be a leading figure in the medical research community. His contributions significantly influence the landscape of treatment for cognitive impairments and neurodegenerative disorders. With his innovative approach and dedication to research, Weiss exemplifies the spirit of invention and the pursuit of improving patient outcomes in healthcare.